Financials data is unavailable for this security.
View more
Year on year Carl Zeiss Meditec AG had net income fall -20.99% from 178.73m to 141.21m despite a 7.82% increase in revenues from 2.07bn to 2.23bn. An increase in the selling, general and administrative costs as a percentage of sales from 27.55% to 28.12% was a component in the falling net income despite rising revenues.
| Gross margin | 52.19% |
|---|---|
| Net profit margin | 5.53% |
| Operating margin | 8.91% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in EURView more
In 2025, Carl Zeiss Meditec AG increased its cash reserves by 34.42%, or 6.98m. The company earned 209.86m from its operations for a Cash Flow Margin of 9.42%. In addition the company used 91.03m on investing activities and also paid 108.83m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in EURView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in EUR
SmartText is unavailable
| Div yield(5 year avg) | 0.90% |
|---|---|
| Div growth rate (5 year) | 1.92% |
| Payout ratio (TTM) | 39.92% |
| EPS growth(5 years) | 3.35 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -22.63 |
More ▼
